Baxter JD - Search Results

1

Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight.

Baxter JD, Webb P, Grover G, Scanlan TS. Baxter JD, et al. Trends Endocrinol Metab. 2004 May-Jun;15(4):154-7. doi: 10.1016/j.tem.2004.03.008. Trends Endocrinol Metab. 2004. PMID: 15109613 Review.

2

Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.

Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS. Grover GJ, et al. Among authors: baxter jd. Endocrinology. 2004 Apr;145(4):1656-61. doi: 10.1210/en.2003-0973. Epub 2003 Dec 30. Endocrinology. 2004. PMID: 14701670

3

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

Baxter JD, Webb P. Baxter JD, et al. Nat Rev Drug Discov. 2009 Apr;8(4):308-20. doi: 10.1038/nrd2830. Nat Rev Drug Discov. 2009. PMID: 19337272 Review.

4

The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.

Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH. Trost SU, et al. Among authors: baxter jd. Endocrinology. 2000 Sep;141(9):3057-64. doi: 10.1210/endo.141.9.7681. Endocrinology. 2000. PMID: 10965874

5

Hormone selectivity in thyroid hormone receptors.

Wagner RL, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, Scanlan TS, Apriletti JW, Baxter JD, West BL, Fletterick RJ. Wagner RL, et al. Among authors: baxter jd. Mol Endocrinol. 2001 Mar;15(3):398-410. doi: 10.1210/mend.15.3.0608. Mol Endocrinol. 2001. PMID: 11222741

6

Selective modulation of thyroid hormone receptor action.

Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS. Baxter JD, et al. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):31-42. doi: 10.1016/s0960-0760(01)00052-8. J Steroid Biochem Mol Biol. 2001. PMID: 11384861 Review.

7

A designed antagonist of the thyroid hormone receptor.

Yoshihara HA, Apriletti JW, Baxter JD, Scanlan TS. Yoshihara HA, et al. Among authors: baxter jd. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2821-5. doi: 10.1016/s0960-894x(01)00521-2. Bioorg Med Chem Lett. 2001. PMID: 11597408

8

Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

Vatner DF, Weismann D, Beddow SA, Kumashiro N, Erion DM, Liao XH, Grover GJ, Webb P, Phillips KJ, Weiss RE, Bogan JS, Baxter J, Shulman GI, Samuel VT. Vatner DF, et al. Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E89-100. doi: 10.1152/ajpendo.00573.2012. Epub 2013 May 7. Am J Physiol Endocrinol Metab. 2013. PMID: 23651850 Free PMC article.

9

Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist.

Baxter JD, Goede P, Apriletti JW, West BL, Feng W, Mellstrom K, Fletterick RJ, Wagner RL, Kushner PJ, Ribeiro RC, Webb P, Scanlan TS, Nilsson S. Baxter JD, et al. Endocrinology. 2002 Feb;143(2):517-24. doi: 10.1210/endo.143.2.8617. Endocrinology. 2002. PMID: 11796506

10

Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Nguyen NH, Apriletti JW, Cunha Lima ST, Webb P, Baxter JD, Scanlan TS. Nguyen NH, et al. Among authors: baxter jd. J Med Chem. 2002 Jul 18;45(15):3310-20. doi: 10.1021/jm0201013. J Med Chem. 2002. PMID: 12109914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

413 results

Search Page